Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 16.273\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a: COc1ccc(-c2cn3nc(SCC(=O)NC4CCCCC4)ccc3n2)cc1
b: CCOC(=O)c1cc(S(=O)(=O)N2CCC(C)CC2)cn1C
Answer: a. COc1ccc(-c2cn3nc(SCC(=O)NC4CCCCC4)ccc3n2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(-c2cn3nc(SCC(=O)NC4CCCCC4)ccc3n2)cc1
COc1ccc(-c2cn3nc(SCC(=O)NC4CCCCC4)ccc3n2)cc1
N-cyclohexyl-2-[2-(4-methoxyphenyl)imidazo[1,2-b]pyridazin-6-yl]sulfanylacetamide